Prenatal SSRI exposure: Effects on later child development

Child Neuropsychology

Volumn 21, Issue 5, 2015, Pages 543-569

  Hermansen, Tone Kristine ^a   Melinder, Annika ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Cognition; Depression; HPA; Prenatal exposure; SSRI

Indexed keywords

ANTIDEPRESSANT AGENT; DOPAMINE; HYDROCORTISONE; NEUROTRANSMITTER; NORADRENALIN; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; BEHAVIOR DISORDER; BRAIN DEVELOPMENT; CHILD DEVELOPMENT; CHILDBIRTH; COGNITION; COGNITIVE DEVELOPMENT; DEPRESSION; DOPAMINE BRAIN LEVEL; DRUG EFFECT; FETUS DEVELOPMENT; FETUS OUTCOME; GENETICS; GLIA CELL; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MOTOR DEVELOPMENT; NERVOUS SYSTEM PARAMETERS; NEURAL PROGRAMMING; NEUROTRANSMISSION; NONHUMAN; NORADRENALIN BRAIN LEVEL; PERINATAL PERIOD; PLACENTA CIRCULATION; PREGNANCY; PREGNANT WOMAN; PRENATAL DRUG EXPOSURE; PSYCHOMOTOR DEVELOPMENT; PUERPERAL DEPRESSION; SEROTONIN BRAIN LEVEL; SOCIAL EVOLUTION; VULNERABLE POPULATION; BRAIN; DRUG EFFECTS; FEMALE; FETOMATERNAL TRANSFUSION; NEWBORN; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PRENATAL EXPOSURE;

ANTIDEPRESSIVE AGENTS; BRAIN; CHILD DEVELOPMENT; DEPRESSION; DEPRESSIVE DISORDER; FEMALE; FETAL DEVELOPMENT; HUMANS; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PRENATAL EXPOSURE DELAYED EFFECTS; SEROTONIN UPTAKE INHIBITORS;

EID: 84940788905     PISSN: 09297049     EISSN: 17444136     Source Type: Journal    
DOI: 10.1080/09297049.2014.942727     Document Type: Article

References (148)

1. Andersen, S. L. (2003). Trajectories of brain development: Point of vulnerability or window of opportunity? Neuroscience and Biobehavioral Reviews, 27(1-2), 3-18. doi:10.1016/s0149-7634(03)00005-8
2. Anderson, P. (2002). Assessment and development of executive function (EF) during childhood. Child Neuropsychology (Neuropsychology, Development and Cognition: Section C), 8(2), 71-82. doi:10.1076/chin.8.2.71.8724
3. Andrews, M. H., & Matthews, S. G. (2004). Programming of the hypothalamo-pituitary-adrenal axis: Serotonergic involvement. Stress: The International Journal on the Biology of Stress, 7(1), 15-27. doi:10.1080/10253890310001650277
4. Arnsten, A. F. T. (2000). Genetics of childhood disorders: XVIII. ADHD, Part 2: Norepinephrine has a critical modulatory influence on prefrontal cortical function. Journal of the American Academy of Child and Adolescent Psychiatry, 39(9), 1201-1203. doi:10.1097/00004583-200009000-00022
5. Ashman, S. B., Dawson, G., & Panagiotides, H. (2008). Trajectories of maternal depression over 7 years: Relations with child psychophysiology and behavior and role of contextual risks. Development and Psychopathology, 20(1), 55-77. doi:10.1017/S0954579408000035
6. Azak, S., Murison, R., Wentzel-Larsen, T., Smith, L., & Gunnar, M. R. (2013). Maternal depression and infant daytime cortisol. Developmental Psychobiology, 55(4), 334-351. doi:10.1002/dev.21033
7. Barnes, N. M., & Sharp, T. (1999). A review of central 5-HT receptors and their function. Neuropharmachology, 38(8), 1083-1152. doi:10.1016/S0028-3908(99)00010-6
8. rd ed.). San Antonio, TX: The Psychologcial Corporation.
9. Belsky, J., & Pluess, M. (2009). Beyond diathesis stress: Differential susceptibility to environmental influences. Psychological Bulletin, 135(6), 885-908. doi:10.1037/a0017376
10. Bhattacharyya, A., Oppenheim, R. W., Prevette, D., Moore, B. W., Brackenbury, R., & Ratner, N. (1992). S100 is present in developing chicken neurons and schwann cell and promotes motor neuron survivalin vivo. Journal of Neurobiology, 23(4), 451-466. doi:10.1002/neu.480230410
11. Bhutta, A. T., Cleves, M. A., Casey, P. H., Cradock, M. M., & Anand, K. J. S. (2002). Cognitive and behavioral outcomes of school-aged children who were born preterm - A Meta-Analysis. Jama-Journal of the American Medical Association, 288(6), 728-737. doi:10.1001/jama.288.6.728
12. Biringer, E., Rongve, A., & Lund, A. (2009). A review of modern antidepressants' effects on neurocognitive function. Current Psychiatry Reviews, 5(3), 164-174. doi:10.2174/157340009788971137
13. Bishop, S. R., Lau, M., Shapiro, S., Carlson, L., Anderson, N. D., Carmody, J., ... Devins, G. (2004). Mindfulness: A proposed operational definition. Clinical Psychology: Science and Practice, 11(3), 230-241. doi:10.1093/clipsy.bph077
14. Blair, C., Granger, D., & Razza, R. P. (2005). Cortisol reactivity is positively related to executive function in preschool children attending head start. Child Development, 76(3), 554-567. doi:10.1111/j.1467-8624.2005.00863.x
15. Boulet, S. L., Schieve, L. A., & Boyle, C. A. (2011). Birth weight and health and developmental outcomes in US children, 1997-2005. Maternal and Child Health Journal, 15(7), 836-844. doi:10.1007/s10995-009-0538-2
16. Brambilla, P., Cipriani, A., Hotopf, M., & Barbui, C. (2005). Side-effect profile of fluoxetine in comparison with other SSRIs, tricyclic and newer antidepressants: A meta-analysis of clinical trial data. Pharmacopsychiatry, 38, 69-77. doi:10.1055/s-2005-837806
17. Branchi, I. (2011). The double edged sword of neural plasticity: Increasing serotonin levels leads to both greater vulnerability to depression and improved capacity to recover. Psychoneuroendocrinology, 36(3), 339-351. doi:10.1016/j.psyneuen.2010.08.011
18. Branchi, I., Francia, N., & Alleva, E. (2004). Epigenetic control of neurobehavioural plasticity: The role of neurotrophins. Behavioural Pharmacology, 15(5), 353-362. doi:10.1097/00008877-200409000-00006
19. Buitelaar, J. K., Huizink, A. C., Mulder, E. J., de Medina, P. G. R., & Visser, G. H. A. (2003). Prenatal stress and cognitive development and temperament in infants. Neurobiology of Aging, 24, SS53-SS60. doi:10.1016/s0197-4580(03)00050-2
20. Casper, R. C., Fleisher, B. E., Lee-Ancajas, J. C., Gilles, A., Gaylor, E., DeBattista, A., & Hoyme, H. E. (2003). Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. The Journal of Pediatrics, 142, 402-408. doi:10.1067/mpd.2003.139
21. Casper, R. C., Gilles, A. A., Fleisher, B. E., Baran, J., Enns, G., & Lazzeroni, L. C. (2011). Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: Effects on neonatal adaptation and psychomotor development. Psychopharmacology (Berl), 217(2), 211-219. doi:10.1007/s00213-011-2270-z
22. Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., ... Poulton, R. (2003). Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science, 301(5631), 386-389. doi:10.1126/science.1083968
23. Chambers, C. D., Johnson, K. A., Dick, L. M., Felix, R. J., & Jones, K. L. (1996). Birth outcomes in pregnant women taking fluoxetine. The New England Journal of Medicine, 335(14), 1010-1015. doi:10.1056/NEJM199610033351402
24. Cohen, J. (1992). Statistical power analysis. Current Directions in Psychological Science, 1(3), 98-101. doi:10.1111/1467-8721.ep10768783
25. Cohn, J. F., & Tronick, E. (1989). Specificity of infants' response to mothers' affective behavior. Journal of the American Academy of Child and Adolescent Psychiatry, 28(2), 242-248. doi:10.1097/00004583-198903000-00016
26. Cools, R., Roberts, A. C., & Robbins, T. W. (2008). Serotoninergic regulation of emotional and behavioural control processes. Trends in Cognitive Sciences, 12(1), 31-40. doi:10.1016/j.tics.2007.10.011
27. Cuijpers, P., Geraedts, A. S., van Oppen, P., Andersson, G., Markowitz, J. C., & van Straten, A. (2011). Interpersonal psychotherapy for depression: A meta-analysis. American Journal of Psychiatry, 168(6), 581-592. doi:10.1176/appi.ajp.2010.10101411
28. Dailly, E., Chenu, F., Renard, C. E., & Bourin, M. (2004). Dopamine, depression and antidepressants. Fundamental & Clinical Pharmacology, 18(6), 601-607. doi:10.1111/j.1472-8206.2004.00287.x
29. Davidson, M. C., Amso, D., Anderson, L. C., & Diamond, A. (2006). Development of cognitive control and executive functions from 4 to 13 years: Evidence from manipulations of memory, inhibition, and task switching. Neuropsychologia, 44(11), 2037-2078. doi:10.1016/j. neuropsychologia.2006.02.006
30. Davis, E. P., & Sandman, C. A. (2010). The timing of prenatal exposure to maternal cortisol and psychosocial stress is associated with human infant cognitive development. Child Development, 81(1), 131-148. doi:10.1111/j.1467-8624.2009.01385.x
31. de Kloet, E. R., Joëls, M., & Holsboer, F. (2005). Stress and the brain: From adaptation to disease. Nature Reviews Neuroscience, 6(6), 463-475. doi:10.1038/nrn1683
32. Deave, T., Heron, J., Evans, J., & Emond, A. (2008). The impact of maternal depression in pregnancy on early child development. \BJOG: An International Journal of Obstetrics & Gynaecology, 115(8), 1043-1051. doi:10.1111/j.1471-0528.2008.01752.x
33. Devlin, A. M., Brain, U., Austin, J., & Oberlander, T. F. (2010). Prenatal exposure to maternal depressed mood and the MTHFR C677T variant affect SLC6A4 methylation in infants at birth. Plos One, 5(8), e12201-e12209. doi:10.1371/journal.pone.0012201
34. Diego, M. A., Field, T., Jones, N. A., Hernandez-Reif, M., Cullen, C., Schanberg, S., & Kuhn, C. (2004). EEG responses to mock facial expressions by infants of depressed mothers. Infant Behavior and Development, 27(2), 150-162. doi:10.1016/j.infbeh.2003.10.001
35. dos Santos, E. S. L., de Kieviet, J. F., Königs, M., van Elburg, R. M., & Oosterlaan, J. (2013). Predictive value of the Bayley scales of infant development on development of very preterm/very low birth weight children: A meta-analysis. Early Human Development, 89(7), 487-496. doi:10.1016/j.earlhumdev.2013.03.008
36. Einarson, T. R., & Einarson, A. (2005). Newer antidepressants in pregnancy and rates of major malformations: A meta-analysis of prospective comparative studies. Pharmacoepidemiology and Drug Safety, 14(12), 823-827. doi:10.1002/pds.1084
37. El Marroun, H., Jaddoe, V. W. V., Hudziak, J. J., Roza, S. J., Steegers, E. A. P., Hofman, A., ... Tiemeier, H. (2012). Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes. Archives of General Psychiatry, 69(7), 706-714. doi:10.1001/archgenpsychiatry.2011.2333
38. Evans, J., Melotti, R., Heron, J., Ramchandani, P., Wiles, N., Murray, L., & Stein, A. (2012). The timing of maternal depressive symptoms and child cognitive development: A longitudinal study. Journal of Child Psychology and Psychiatry, 53(6), 632-640. doi:10.1111/j.1469-7610.2011.02513.x
39. Evers, E. A. T., van der Veen, F. M., Fekkes, D., & Jolles, J. (2007). Serotonin and cognitive flexibility: Neuroimaging studies into the effect of acute tryptophan depletion in healthy volunteers. Current Medicinal Chemistry, 14(28), 2989-2995. doi:10.2174/092986707782794032
40. Fattal-Valevski, A., Leitner, Y., Geva, R., Bassan, H., Goez, H., Jaffa, A. J., & Harel, S. (2001). The effect of intrauterine growth restriction on the development and health of children. Nutrition and Health (Bicester), 15(3-4), 169-175. doi:10.1177/026010600101500404
41. Fernández-Pastor, B., Ortega, J. E., & Meana, J. J. (2013). Involvement of serotonin 5-HT3 receptors in the modulation of noradrenergic transmission by serotonin reuptake inhibitors: A microdialysis study in rat brain. Psychopharmacology, 229, 331-344. doi:10.1007/s00213-013-3112-y
42. Field, T., Diego, M., Dieter, J., Hernandez Reif, M., Schanberg, S., Kuhn, C., ... Bendell, D. (2004). Prenatal depression effects on the fetus and the newborn. Infant Behavior and Development, 27(2), 216-229. doi:10.1016/j.infbeh.2003.09.010
43. Field, T., Diego, M., Hernandez-Reif, M., Vera, Y., Gil, K., Schanberg, ... Gonzalez-Garcia, A. (2004). Prenatal maternal biochemistry predicts neonatal biochemistry. International Journal of Neuroscience, 114(8), 933-945. doi:10.1080/00207450490461305
44. Field, T. M. (1984). Early interactions between infants and their postpartum depressed mothers. Infant Behavior and Development, 7(4), 517-522. doi:10.1016/s0163-6383(84)80010-7
45. Fikke, L. T., Melinder, A., & Landrø, N. I. (2013). The effects of acute tryptophan depletion on impulsivity and mood in adolescents engaging in non-suicidal self-injury. Human Psychopharmacology: Clinical and Experimental, 28(1), 61-71. doi:10.1002/hup.2283
46. Fitzgerald, P. J. (2011). A neurochemical yin and yang: Does serotonin activate and norepinephrine deactivate the prefrontal cortex? Psychopharmacology, 213, 171-182. doi:10.1007/s00213-010-1856-1
47. Fjorback, L. O., Arendt, M., Ørnbøl, E., Fink, P., & Walach, H. (2011). Mindfulness-based stress reduction and mindfulness-based cognitive therapy - A systematic review of randomized controlled trials. Acta Psychiatrica Scandinavica, 124(2), 102-119. doi:10.1111/j.1600-0447.2011.01704.x
48. Galbally, M., Lewis, A. J., & Buist, A. (2011). Developmental outcomes of children exposed to antidepressants in pregnancy. Aust N Z J Psychiatry, 45(5), 393-399. doi:10.3109/00048674.2010.549995
49. Gaspar, P., Cases, O., & Maroteaux, L. (2003). The developmental role of serotonin: News from mouse molecular genetics. Nature Reviews Neuroscience, 4(12), 1002-1012. doi:10.1038/nrn1256
50. Gentile, S. (2010). Neurodevelopmental effects of prenatal exposure to psychotropic medications. Depress Anxiety, 27(7), 675-686. doi:10.1002/da.20706
51. Gentile, S., Rossi, A., & Bellantuono, C. (2007). SSRIs during breastfeeding: Spotlight on milk-toplasma ratio. Archives of Womens Mental Health, 10(2), 39-51. doi:10.1007/s00737-007-0173-0
52. Ghodsian, M., Zajicek, E., & Wolkind, S. (1984). A longitudinal study of maternal depression and child behaviour problems. Journal of Child Psychology and Psychiatry and Allied Disciplines, 25(1), 91-109. doi:10.1111/j.1469-7610.1984.tb01721.x
53. Gonzalez-Martinez, T., Perez-Pinera, P., Diaz-Esnal, B., & Vega, J. A. (2003). S-100 proteins in the human peripheral nervous system. Microscopy Research and Technique, 60(6), 633-638. doi:10.1002/jemt.10304
54. Gunnar, M. R., & Fisher, P. A. (2006). Bringing basic research on early experience and stress neurobiology to bear on preventive interventions for neglected and maltreated children. Development and Psychopathology, 18(3), 651-677. doi:10.1017/s0954579406060330
55. Hanley, G. E., Brain, U., & Oberlander, T. F. (2013). Infant developmental outcomes following prenatal exposure to antidepressants, and maternal depressed mood and positive affect. Early Human Development, 89(8), 519-524. doi:10.1016/j.earlhumdev.2012.12.012
56. Hayden, E. P., Hanna, B., Sheikh, H. I., Laptook, R. S., Kim, J., Singh, S. M., & Klein, D. N. (2013). Child dopamine active transporter 1 genotype and parenting: Evidence for evocative gene-environment correlations. Development and Psychopathology, 25(1), 163-173. doi:10.1017/S0954579412000971
57. Hayes, L. J., Goodman, S. H., & Carlson, E. (2013). Maternal antenatal depression and infant disorganized attachment at 12 months. Attachment & Human Development, 15(2), 133-153. doi:10.1080/14616734.2013.743256
58. Hendrick, V., Stowe, Z. N., Altshuler, L. L., Hwang, S., Lee, E., & Haynes, D. (2003). Placental passage of antidepressant medications. American Journal of Psychiatry, 160(5), 993-996. doi:10.1176/appi.ajp.160.5.993
59. Herlenius, E., & Lagercrantz, H. (2004). Development of neurotransmitter systems during critical periods. Experimental Neurology, 190, 8-21. doi:10.1016/j.expneurol.2004.03.027
60. Hoenig, J. M., & Heisey, D. M. (2001). The abuse of power: The pervasive fallacy of power calculations for data analysis. The American Statistician, 55(1), 19-24. doi:10.1198/000313001300339897
61. Homberg, J. R., & Lesch, K. P. (2011). Looking on the bright side of serotonin transporter gene variation. Biological Psychiatry, 69, 513-519. doi:10.1016/j.biopsych.2010.09.024
62. Homberg, J. R., Schubert, D., & Gaspar, P. (2010). New perspectives on the neurodevelopmental effects of SSRIs. Trends in Pharmacological Sciences, 31(2), 60-65. doi:10.1016/j.tips.2009.11.003
63. th ed.). Boston, MA: Wadsworth, Cengage Learning.
64. Huizink, A. C., de Medina, P. G. R., Mulder, E. J. H., Visser, G. H. A., & Buitelaar, J. K. (2003). Stress during pregnancy is associated with developmental outcome in infancy. Journal of Child Psychology and Psychiatry and Allied Disciplines, 44(6), 810-818. doi:10.1111/1469-7610.00166
65. Huybrechts, K. F., Palmsten, K., Mogun, H., Kowal, M., Avorn, J., Setoguchi-Iwata, S., & Hernández-Díaz, S. (2013). National trends in antidepressant medication treatment among publicly insured pregnant women. General Hospital Psychiatry, 35(3), 265-271. doi:10.1016/j.genhosppsych.2012.12.010
66. Iqbal, M., Audette, M. C., Petropoulos, S., Gibb, W., & Matthews, S. G. (2012). Placental drug transporters and their role in fetal protection. Placenta, 33(3), 137-142. doi:10.1016/j.placenta.2012.01.008
67. Isbister, G. K., Dawson, A., Whyte, I. M., Prior, F. H., Clancy, C., & Smith, A. J. (2001). Neonatal paroxetine withdrawal syndrome or actually serotonin syndrome? Archives of Disease in Childhood, 85(2), F147-F148. Retrieved from http://fn.bmj.com/content/85/2/F145.7.full
68. Jacobs, B. L., & Fornal, C. A. (1997). Serotonin and motor activity. Current Opinion in Neurobiology, 7(6), 820-825. doi:10.1016/s0959-4388(97)80141-9
69. Karlsson, S., Rieckmann, A., Karlsson, P., Farde, L., Nyberg, L., & Bäckman, L. (2011). Relationship of dopamine D1 receptor binding in striatal and extrastriatal regions to cognitive functioning in healthy humans. NeuroImage, 57(2), 346-351. doi:10.1016/j.neuroimage.2011.04.047
70. Karpova, N. N., Lindholm, J., Pruunsild, P., Timmusk, T., & Castrén, E. (2009). Long-lasting behavioural and molecular alterations induced by early postnatal fluoxetine exposure are restored by chronic fluoxetine treatment in adult mice. European Neuropsychopharmacology, 19(2), 97-108. doi:10.1016/j.euroneuro.2008.09.002
71. Kieler, H., Artam, M., Engeland, A., Ericsson, Ol., Furu, K., Gissler, M., ... Haglund, B. (2012). Selective Serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: Population based cohort study from the five Nordic countries. British Medical Journal, 344, 1-9. doi:10.1136/bmj.d8012
72. Kiser, D., SteemerS, B., Branchi, I., & Homberg, J. R. (2012). The reciprocal interaction between serotonin and social behaviour. Neuroscience and Biobehavioral Reviews, 36(2), 786-798. doi:10.1016/j.neubiorev.2011.12.009
73. Klimek, V., & Nielsen, M. (1987). Chronic treatment with antidepressants decreases the number of [3H]SCH 23390 binding sites in the rat striatum and limbic system. European Journal of Pharmacology, 139(2), 163-169. doi:10.1016/0014-2999(87)90248-2
74. Klinger, G., Frankenthal, D., Merlob, P., Diamond, G., Sirota, L., Levinson-Castiel, R., Linder, N., Stahl, B., & Inbar, D. (2011). Long-term outcome following selective serotonin reuptake inhibitor induced neonatal abstinence syndrome. Journal of Perinatology, 31(9), 615-620. doi:10.1038/jp.2010.211
75. Klinger, G., & Merlob, P. (2008). Selective serotonin reuptake inhibitor induced neonatal abstinence syndrome. Israel Journal of Psychiatry and Related Sciences, 45(2), 107-113. Retrieved from http://acupuncture.doctorsonly.co.il/wp-content/uploads/2011/12/2008-2-7.pdf
76. Konijnenberg, C., & Melinder, A. (2013). Neurodevelopmental investigation of the mirror neurone system in children of women receiving opioid maintenance therapy during pregnancy. Addiction, 108(1), 154-160. doi:10.1111/j.1360-0443.2012.04006.x
77. Koutra, K., Chatzi, L., Bagkeris, M., Vassilaki, M., Bitsios, P., & Kogevinas, M. (2013). Antenatal and postnatal maternal mental health as determinants of infant neurodevelopment at 18 months of age in a mother-child cohort (Rhea Study) in Crete, Greece. Social Psychiatry and Psychiatric Epidemiology, 48(8), 1335-1345. doi:10.1007/s00127-012-0636-0
78. Laine, K., Heikkinen, T., Ekblad, U., & Kero, P. (2003). Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Archives of General Psychiatry, 60(7), 720-726. doi:10.1001/archpsyc.60.7.720
79. Lampe, L., Coulston, C. M., & Berk, L. (2013). Psychological management of unipolar depression. Acta Psychiatrica Scandinavica, 127, 24-37. doi:10.1111/acps.12123
80. Lenth, R. V. (2001). Some practical guidelines for effective sample size determination. The American Statistician, 55(3), 187-193. doi:10.1198/000313001317098149
81. Lenth, R. V. (2006-2009). Java Applets for Power and Sample Size [Computer software]. Retrieved from http://www.stat.uiowa.edu/~rlenth/Power
82. Lesch, K.-P. (2007). Linking emotion to the social brain - The role of the serotonin transporter in human social behaviour. Embo Reports, 8, SS24-SS29. doi:10.1038/sj.embor.7401008
83. Lundy, B. L. (2002). Paternal socio-psychological factors and infant attachment: The mediating role of synchrony in father-infant interactions. Infant Behavior and Development, 25(2), 221-236. doi:10.1016/s0163-6383(02)00123-6
84. Lundy, B. L., Jones, N. A., Field, T., Nearing, G., Davalos, M., Pietro, P. A., ... Kuhn, C. (1999). Prenatal depression effects on neonates. Infant Behavior and Development, 22(1), 119-129. doi:10.1016/s0163-6383(99)80009-5
85. Lupien, S. J., McEwen, B. S., Gunnar, M. R., & Heim, C. (2009). Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nature Reviews Neuroscience, 10(6), 434-445. doi:10.1038/nrn2639
86. Marcovitch, S., Goldberg, S., Gold, A., Washington, J., Wasson, C., Krekewich, K., & HandleyDerry, M. (1997). Determinants of behavioural problems in Romanian children adopted in Ontario. International Journal of Behavioral Development, 20(1), 17-31. doi:10.1080/016502597385414
87. Martins, C., & Gaffan, E. A. (2000). Effects of early maternal depression on patterns of infantmother attachment: A meta-analytic investigation. Journal of Child Psychology and Psychiatry and Allied Disciplines, 41(6), 737-746. doi:10.1111/1469-7610.00661
88. McCarthy, D. (1972). The McCarthy scales of children's abilities. New York, NY: The Psychological Corporation.
89. Meier, E., Hertz, L., & Schousboe, A. (1991). Neurotransmitters as developmental signals. Neurochemistry International, 19(1-2), 1-15. doi:10.1016/0197-0186(91)90113-r
90. Melinder, A., Forbes, D., Tronick, E., Fikke, L., & Gredebäck, G. (2010). The development of the still-face effect: Mothers do matter. Infant Behavior and Development, 33(4), 472-481. doi:10.1016/j.infbeh.2010.05.003
91. Melinder, A., Konijnenberg, C., & Sarfi, M. (2013). Deviant smooth pursuit in preschool children exposed prenatally to methadone or buprenorphine and tobacco affects integrative visuomotor capabilities. Addiction, 108, 2175-2182. doi:10.1111/add.12267
92. Mendelsohn, D., Riedel, W. J., & Sambeth, A. (2009). Effects of acute tryptophan depletion on memory, attention and executive functions: A systematic review. Neuroscience and Biobehavioral Reviews, 33(6), 926-952. doi:10.1016/j.neubiorev.2009.03.006
93. Mercier, G., Lennon, A. M., Renouf, B., Dessouroux, A., Ramaugé, M., Courtin, F., & Pierre, M. (2004). MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes. Journal of Molecular Neuroscience, 24(2), 207-216. doi:10.1385/jmn:24:2:207
94. Mesman, J., van Ijzendoorn, M. H., & Bakermans-Kranenburg, M. J. (2009). The many faces of the Still-Face Paradigm: A review and meta-analysis. Developmental Review, 29(2), 120-162. doi:10.1016/j.dr.2009.02.001
95. Misri, S., Reebye, P., Kendrick, K., Carter, D., Ryan, D., Grunau, R. E., & Oberlander, T. F. (2006). Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications. American Journal of Psychiatry, 163(6), 1026-1032. doi:10.1176/appi.ajp.163.6.1026
96. Monk, C. S., Spicer, J., & Champagne, F. A. (2012). Linking prenatal maternal adversity to developmental outcomes in infants: The role of epigenetic pathways. Development and Psychopathology, 24, 1361-1376. doi:10.1017/S0954579412000764
97. Morelli, E., Moore, H., Rebello, T. J., Gray, N., Steele, K., Esposito, E., ... Ansorge, M. S. (2011). Chronic 5-Ht transporter blockade reduces DA signaling to elicit basal ganglia dysfunction. Journal of Neuroscience, 31(44), 15742-15750. doi:10.1523/jneurosci.2989-11.2011
98. Moret, C., & Briley, M. (2011). The importance of norepinephrine in depression. Neurpsychiatric Disease and Treatment, 7(1), 9-13. doi:10.2147/NDT.S19619
99. Mueller, A., Brocke, B., Fries, E., Lesch, K.-P., & Kirschbaum, C. (2010). The role of the serotonin transporter polymorphism for the endocrine stress response in newborns. Psychoneuroendocrinology, 35(2), 289-296. doi:10.1016/j.psyneuen.2009.07.002
100. Murray, L., Hipwell, A., & Hooper, R., Stein, A., Cooper, P. (1996). The cognitive development of 5-year-old children of postnatally depressed mothers. Journal of Child Psychology and Psychiatry and Allied Disciplines, 37(8), 927-935. doi:10.1111/j.1469-7610.1996.tb01490.x
101. Nordeng, H., Lindemann, R., Perminov, K. V., & Reikvam, A. (2001). Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors. Acta Paediatrica, 90(3), 288-291. doi:10.1080/080352501300067596
102. Nordeng, H., van Gelder, M. M., Spigset, O., Koren, G., Einarson, A., & Eberhard-Gran, M. (2012). Pregnancy outcome after exposure to antidepressants and the role of maternal depression: Results from the Norwegian Mother and Child Cohort Study. Journal of Clinical Psychopharmacology, 32(2), 186-194. doi:10.1097/JCP.0b013e3182490eaf
103. Nulman, I., & Koren, G. (1996). The safety of fluoxetine during pregnancy and lactation. Teratology, 53, 304-308. doi:10.1002/(SICI)1096-9926(199605)53:5〈304::AID-TERA4〉3.0.CO;2-0
104. Nulman, I., Koren, G., Rovet, J., Barrera, M., Pulver, A., Streiner, D., & Feldman, B. (2012). Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression. The American Journal of Psychiatry, 169 (11), 1165-1174. doi:10.1176/appi.ajp.2012.11111721
105. Nulman, I., Rovet, J., Stewart, D. E., & Wolpin, J. (1997). Neurodevelopment of children exposed in utero to antidepressant drugs. The New England Journal of Medicine, 336, 258-262. doi:10.1056/NEJM199701233360404
106. Nulman, I., Rovet, J., Stewart, D., Kulin, N. A., & Koren, G. (1996). Neurodevelopment of children exposed to fluoxetine (FL) in utero: A prospective longitudinal study. Clinical Pharmacology and Therapeutics, 59(2), 159-159. doi:10.1038/sj.clpt.1996.134
107. Nulman, I., Rovet, J., Stewart, D. E., Wolpin, J., Pace-Asciak, P., Shuhaiber, S., & Koren, G. (2002). Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: A prospective, controlled study. American Journal of Psychiatry, 159(11), 1889-1895. doi:10.1176/appi.ajp.159.11.1889
108. Oberlander, T. F. (2012). Fetal serotonin signaling: Setting pathways for early childhood development and behavior. Journal of Adolescent Health, 51(2), SS9-SS16. doi:10.1016/j.jadohealth.2012.04.009
109. Oberlander, T. F., Grunau, R. E., Fitzgerald, C., Papsdorf, M., Rurak, D., & Riggs, W. (2005). Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure. Pediatrics, 115(2), 411-425. doi:10.1542/peds.2004-0420
110. Oberlander, T. F., Misri, S., Fitzgerald, C. E., Kostaras, X., Rurak, D., & Riggs, W. (2004). Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure. The Journal of clinical psychiatry, 65(2), 230-237. doi:10.4088/JCP.v65n0214
111. Oberlander, T. F., Reebye, P., Misri, S., Papsdorf, M., Kim, J., & Grunau, R. E. (2007). Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy. Archives of Pediatrics & Adolescent Medicine, 161(1), 22-29. doi:10.1001/archpedi.161.1.22
112. Oberlander, T. F., Warburton, W., Misri, S., Aghajanian, J., & Hertzman, C. (2006). Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Archives of General Psychiatry, 63(8), 898-906. doi:10.1001/archpsyc.63.8.898
113. Oved, K., Morag, A., Pasmanik-Chor, M., Rehavi, M., Shomron, N., & Gurwitz, D. (2013). Genome-wide expression profiling of human lymphoblastoid cell lines implicates integrin beta-3 in the mode of action of antidepressants. Translational Psychiatry, 3, e313-e319. doi:10.1038/tp.2013.86
114. Pawluski, J. L., Galea, L. A. M., Brain, U., Papsdorf, M., & Oberlander, T. F. (2009). Neonatal S100B protein levels after prenatal exposure to selective serotonin reuptake inhibitors. Pediatrics, 124(4), e662-670. doi:10.1542/peds.2009-0442
115. Pedersen, L. H., Henriksen, T. B., Bech, B. H., Licht, R. W., Kjaer, D., & Olsen, J. (2013). Prenatal antidepressant exposure and behavioral problems in early childhood - a cohort study. Acta Psychiatrica Scandinavica, 127(2), 126-135. doi:10.1111/acps.12032
116. Pedersen, L. H., Henriksen, T. B., & Olsen, J. (2010). Fetal exposure to antidepressants and normal milestone development at 6 and 19 months of age. Pediatrics, 125(3), e600-608. doi:10.1542/peds.2008-3655
117. Pluess, M., Velders, F. P., Belsky, J., van Ijzendoorn, M. H., Bakermans-Kranenburg, M. J., Jaddoe, V. W. V., ... Tiemeier, H. (2011). Serotonin transporter polymorphism moderates effects of prenatal maternal anxiety on infant negative emotionality. Biological Psychiatry, 69(6), 520-525. doi:10.1016/j.biopsych.2010.10.006
118. Rampono, J., Proud, S., Hackett, L. P., Kristensen, J. H., & Ilett, K. F. (2004). A pilot study of newer antidepressant concentrations in cord and maternal serum and possible effects in the neonate. The International Journal of Neuropsychopharmacology, 7(3), 329-334. doi:10.1017/s1461145704004286
119. Rampono, J., Simmer, K., Ilett, K., Hackett, L., Doherty, D., Elliot, R., ... Forman, T. (2009). Placental transfer of SSRI and SNRI antidepressants and effects on the neonate. Pharmacopsychiatry, 42(3), 95-100. doi:10.1055/s-0028-1103296
120. Reebye, P. N., Morison, S. J., Panikkar, H., Misri, S., & Grunau, R. E. (2002). Affect expression in prenatally psychotropic exposed and nonexposed mother-infant dyads. Infant Mental Health Journal, 23(4), 403-416. doi:10.1002/imhj.10025
121. Sameroff, A. J. (1975). Early influences on development: Fact or fancy? Merill-Palmer Quarterly-Journal of Developmental Psychology, 21(4), 267-294. Retrieved from http://www.jstor.org/stable/pdfplus/23083878.pdf?acceptTC=true&jpdConfirm=true
122. Sameroff, A. J. (Ed.). (2009). The transactional model of development: How children and contexts shape each other. Washington, DC: American Psychological Association.
123. Sanz, E. J., De-las-Cuevas, C., Kiuru, A., Bate, A., & Edwards, R. (2005). Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: A database analysis. Lancet, 365(9458), 482-487. doi:10.1016/S0140-6736(05)17865-9
124. Sapolsky, R. M., Krey, L. C., & McEwen, B. S. (1986). Glucocorticoid toxicity in the Hippocampus - Reversal by supplementation with brain fuels. Endocrine Reviews, 7(3), 284-301. doi:10.1210/edrv-7-3-284
125. Sarfi, M., Martinsen, H., Bakstad, B., Roislien, J., & Waal, H. (2009). Patterns in sleep-wakefulness in three-month old infants exposed to methadone or buprenorphine. Early Human Development, 85(12), 773-778. doi:10.1016/j.earlhumdev.2009.10.006
126. Sarfi, M., Smith, L., Waal, H., & Sundet, J. M. (2011). Risks and realities: Dyadic interaction between 6-month-old infants and their mothers in opioid maintenance treatment. Infant Behavior and Development, 34(4), 578-589. doi:10.1016/j.infbeh.2011.06.006
127. Seckl, J. R. (2007). Glucocorticoids, developmental "programming" and the risk of affective dysfunction. Progress in Brain Research, 167, 17-34. doi:10.1016/S0079-6123(07)67002-2
128. Selinfreund, R. H., Barger, S. W., Pledger, W. J., & Vaneldik, L. J. (1991). Neurotrophic protein S100-Beta stimulates glial-cell proliferation. Proceedings of the National Academy of Sciences of the United States of America, 88(9), 3554-3558. doi:10.1073/pnas.88.9.3554
129. Simpson, K. L., Weaver, K. J., de Villers-Sidani, E., Cai, Z., Pang, Y., Rodriguez-Porcel, ... Lin, R. C. S. (2011). Perinatal antidepressant exposure alters cortical network function in rodents. Proceedings of the National Academy of Sciences of the United States of America, 108(45), 18465-18470. doi:10.1073/pnas.1109353108
130. Sonuga-Barke, E. J., Oades, R. D., Psychogiou, L., Chen, W., Franke, B., Buitelaar, J., ... Faraone, S. V. (2009). Dopamine and serotonin transporter genotypes moderate sensitivity to maternal expressed emotion: The case of conduct and emotional problems in attention deficit/hyperactivity disorder. Journal of Child Psychology and Psychiatry, 50(9), 1052-1063. doi:10.1111/j.1469-7610.2009.02095.x
131. Sternbach, H. (1991). The serotonin syndrome. American Journal of Psychiatry, 148(6), 705-713. Retrieved from http://journals.psychiatryonline.org/data/Journals/AJP/3556/705.pdf
132. Sun, M., Kingdom, J., Baczyk, D., Lye, S. J., Matthews, S. G., & Gibb, W. (2006). Expression of the multidrug resistance P-glycoprotein, (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation. Placenta, 27(6-7), 602-609. doi:10.1016/j.placenta.2005.05.007
133. Syme, M. R., Paxton, J. W., & Keelan, J. A. (2004). Drug transfer and metabolism by the human placenta. Clinical Pharmacokinetics, 43(8), 487-514. doi:10.2165/00003088-200443080-00001
134. Takashi, H., Kato, M., Takano, H., Arakawa, R., Okumura, M., Otsuka, T., ... & Suhara, T. (2008). Differential contributions of prefrontal and hippocampal dopamine D1 and D2 receptors in human cognitive functions. Journal of Neuroscience, 28(46), 12032-12038. doi:10.1523/JNEUROSCI.3446-08.2008
135. Taylor, H. G., Minich, N., Bangert, B., Filpek, P. A., & Hack, M. (2004). Long-term neuropsychological outcomes of very low birth weight: Associations with early risks for periventricular brain insults. Journal of the International Neuropsychological Society, 10(7), 987-1004. doi:10.1017/s1355617704107078
136. Teasdale, J. D., Segal, Z. V., Williams, J. M. G., Ridgeway, V. A., Soulsby, J. M., & Lau, M. A. (2000). Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Journal of Consulting and Clinical Psychology, 68(4), 615-623. doi:10.1037/0022-006X.68.4.615
137. Tronick, E., & Reck, C. (2009). Infants of depressed mothers. Harvard Review of Psychiatry, 17(2), 147-156. doi:10.1080/10673220902899714
138. Troutman, B. R., & Momany, A. M. (2012). Use of selective serotonin reuptake inhibitors during pregnancy and disorganised infant-mother attachment. Journal of Reproductive and Infant Psychology, 30(3), 261-277. doi:10.1080/02646838.2012.717263
139. Van Batenburg-Eddes, T., Brion, M. J., Henrichs, J., Jaddoe, V. W. V., Hofman, A., Verhulst, F. C., ... Tiemeier, H. (2013). Parental depressive and anxiety symptoms during pregnancy and attention problems in children: A cross-cohort consistency study. Journal of Child Psychology and Psychiatry, 54(5), 591-600. doi:10.1111/jcpp.12023
140. Volkow, N. D., Gur, R. C., Wang, G.-J., Fowler, J. S., Moberg, P. J., Ding, Y.-S., ... Logan, J. (1998). Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. The American Journal of Psychiatry, 155(3), 344-349. Retrieved from http://journals.psychiatryonline.org/article.aspx?articleid=172737
141. Weaver, K. J., Paul, I. A., Lin, R. C. S., & Simpson, K. L. (2010). Neonatal exposure to citalopram selectively alters the expression of the serotonin transporter in the hippocampus: Dose-dependent effects. The Anatomical Record: Advances in Integrative Anatomy and Evolutionary Biology, 293(11), 1920-1932. doi:10.1002/ar.21245
142. rd ed (WPPSI-III). San Antonio, TX: Harcourt Assessment.
143. th ed.). London: Pearson Assessment.
144. Weinstock, M. (1997). Does prenatal stress impair coping and regulation of hypothalamic-pituitary-adrenal axis? Neuroscience and Biobehavioral Reviews, 21(1), 1-10. doi:10.1016/s0149-7634(96)00014-0
145. Williams, S. K., Lauder, J. M., & Johns, J. M. (2011). Prenatal cocaine disrupts serotonin signaling-dependent behaviors: Implications for sex differences, early stress and prenatal SSRI exposure. Current Neuropharmacology, 9(3), 478-511. doi:10.2174/157015911796557957
146. Wu, C. K., Chen, K. C., Chen, P. S., Chiu, N. T., Yeh, T. L., Lee, I. H., & Yang, Y. K. (2013). No changes in striatal dopamine transporter in antidepressant-treated patients with major depression. International Clinical Psychopharmacology, 28(3), 141-144. doi:10.1097/YIC.0b013e32835ebcd7
147. Zimmermann, P., Mohr, C., & Spangler, G. (2009). Genetic and attachment influences on adolescents' regulation of autonomy and aggressiveness. Journal of Child Psychology and Psychiatry, 50(11), 1339-1347. doi:10.1111/j.1469-7610.2009.02158.x
148. Zusso, M., Debetto, P., Guidolin, D., Barbierato, M., Manev, H., & Giusti, P. (2008). Fluoxetine-induced proliferation and differentiation of neural progenitor cells isolated from rat postnatal cerebellum. Biochemical Pharmacology, 76(3), 391-403. doi:10.1016/j.bcp.2008.05.014